The purpose of this study is to evaluate topotecan and melphalan for retinoblastoma patients.
To evaluate the effectiveness and complications of topotecan and melphalan for intraocular injection in retinoblastoma patients.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
50
Sun Yat-sen University
Guangzhou, Guangdong, China
RECRUITINGEyeball-sparing rate
Eyeball-sparing rate during chemotherapy in retinoblastoma patients
Time frame: 5 years after chemotherapy
Side effects
Side effects during and after chemotherapy in retinoblastoma patients
Time frame: 5 years after chemotherapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.